Literature DB >> 18467164

Enhanced detection of respiratory viruses using cryopreserved R-Mix ReadyCells.

Jang Su Kim1, Sun Hyung Kim, Sook Young Bae, Chae Seung Lim, Young Kee Kim, Kap No Lee, Chang Kyu Lee.   

Abstract

BACKGROUND: R-Mix, which contains a fresh mixture of two cell lines, Mv1Lu (mink lung cells) and A549 cells, has shown good sensitivity and specificity for respiratory virus culture. However, it has until recently only been available in North America, in part due to the shipping constraints associated with cell aging and the difficulty in providing these cells to hard to reach regions. Recently, cryopreserved R-Mix ReadyCells for longer storage were developed. These cells, which are shipped on dry ice and have a shelf life as long as 6 months from date of manufacture, can be thawed and used as needed with minimal addition of refeeding media.
OBJECTIVE: Assess the potential for cryopreserved R-Mix ReadyCells to replace conventional culture. STUDY
DESIGN: Two hundred and twenty-three nasopharyngeal aspirates confirmed as respiratory virus-positive by conventional culture were inoculated into cryopreserved R-Mix ReadyCells and re-inoculated into conventional culture cells simultaneously. After 1 and 3 days of incubation cryopreserved R-Mix ReadyCells and conventional culture cells were screened using a respiratory virus fluorescent antibody pool for the detection of seven major respiratory viruses (influenza A and B viruses, parainfluenza 1, 2 and 3 viruses, respiratory syncytial virus and adenovirus). Positive pool results were further differentiated with specific monoclonal antibodies against the individual viruses.
RESULTS: After 1 day of incubation detection rates for conventional culture were 25%, 39%, 39%, 49%, and 10% for influenza A virus, influenza B virus, parainfluenza viruses, respiratory syncytial virus, and adenovirus, respectively. Corresponding detection rates for cryopreserved R-Mix ReadyCells were 78%, 91%, 72%, 81%, and 65%. Average detection rates of cryopreserved R-Mix ReadyCells for all respiratory viruses were 80% after 1 day incubation and 95% after 3 days incubation, compared to 35% and 70% by conventional culture.
CONCLUSION: The cryopreserved R-Mix ReadyCells system offers a highly sensitive and rapid method for detection of respiratory viruses that may allow it to replace conventional cell culture systems.

Entities:  

Mesh:

Year:  2008        PMID: 18467164     DOI: 10.1016/j.jcv.2008.03.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Point: is the era of viral culture over in the clinical microbiology laboratory?

Authors:  Richard L Hodinka
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

2.  Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.

Authors:  E Terletskaia-Ladwig; M Eggers; S Meier; M Leinmüller; F Schneider; M Schmid; M Enders
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

3.  Viral etiologies of lower respiratory tract infections among Egyptian children under five years of age.

Authors:  Caroline F Shafik; Emad W Mohareb; Aymen S Yassin; Madgy A Amin; Amani El Kholy; Hanaa El-Karaksy; Fouad G Youssef
Journal:  BMC Infect Dis       Date:  2012-12-13       Impact factor: 3.090

4.  Differentiation of Cytopathic Effects (CPE) induced by influenza virus infection using deep Convolutional Neural Networks (CNN).

Authors:  Ting-En Wang; Tai-Ling Chao; Hsin-Tsuen Tsai; Pi-Han Lin; Yen-Lung Tsai; Sui-Yuan Chang
Journal:  PLoS Comput Biol       Date:  2020-05-13       Impact factor: 4.475

5.  Comparison of different cell substrates on the measurement of human influenza virus neutralizing antibodies.

Authors:  Weiguo Zhai; Dan Ning Zhang; Cecilia Mai; Justin Choy; Gary Jian; Kuldip Sra; Mark S Galinski
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 6.  Developments in tissue culture detection of respiratory viruses.

Authors:  Alexander J McAdam; Ann Marie Riley
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.